| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Paul A. Offit | Q7152812 |
| P2093 | author name string | Offit PA | |
| P2860 | cites work | Identification of group A rotavirus gene 4 types by polymerase chain reaction | Q28776682 |
| Rotavirus protein structure and function | Q30420560 | ||
| Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus | Q31160938 | ||
| Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4 | Q33795720 | ||
| Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk. | Q33902442 | ||
| Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype | Q33927670 | ||
| Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic | Q34193979 | ||
| Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis | Q34202510 | ||
| Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh. | Q53436398 | ||
| Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. | Q54105146 | ||
| Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. | Q54329594 | ||
| Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. | Q54423952 | ||
| Protection against cholera in breast-fed children by antibodies in breast milk. | Q55062828 | ||
| Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea | Q56816816 | ||
| Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age | Q56816817 | ||
| Active protection against rotavirus infection of mice following intraperitoneal immunization | Q57072462 | ||
| Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody | Q57072474 | ||
| Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfections | Q57112806 | ||
| An outbreak of rotavirus-associated neonatal necrotizing enterocolitis | Q57114427 | ||
| Neonatal rotavirus infection: Role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection | Q57114921 | ||
| Cord blood and breast-milk antibodies in neonatal rotavirus infection | Q57115443 | ||
| Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea | Q57926537 | ||
| Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus | Q57952059 | ||
| Antibody-forming cells in human colostrum after oral immunisation | Q59074942 | ||
| Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines | Q64128669 | ||
| Rotavirus as a cause of diarrheal morbidity and mortality in the United States | Q64129980 | ||
| Detection of rotavirus in respiratory secretions of children with pneumonia | Q64380874 | ||
| Prevention of Rotavirus-Induced Diarrhea in Neonatal Mice Born to Dams Immunized with Empty Capsids of Simian Rotavirus SA-II | Q64896578 | ||
| Selective primary health care: an interim strategy for disease control in developing countries | Q66833955 | ||
| Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance | Q67258021 | ||
| Production of coproantibodies and immune complexes in piglets infected with rotavirus | Q67268140 | ||
| Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children | Q67297435 | ||
| Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups | Q67492593 | ||
| Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity | Q67503933 | ||
| Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates | Q67507828 | ||
| Benign acute myositis associated with rotavirus gastroenteritis | Q67580367 | ||
| The effects of maternal antibodies on neonatal rotavirus infection | Q67777450 | ||
| Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand | Q67903498 | ||
| Enteral immunoglobulins for treatment of protracted rotaviral diarrhea | Q67998031 | ||
| Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes | Q68252753 | ||
| Safety and Immunogenicity of Human Rotavirus Vaccine Strain M37 in Adults, Children, and Infants | Q68254459 | ||
| The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants | Q68447764 | ||
| Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development | Q68453526 | ||
| Impact of rotavirus infection at a large pediatric hospital | Q68473397 | ||
| Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants | Q39044644 | ||
| Secretory antibody directed against rotavirus in human milk—measurement by means of enzyme-linked immunosorbent assay | Q39205546 | ||
| Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children | Q39281593 | ||
| Neonatal Rotavirus Infection and Its Relation to Cord Blood Antibodies | Q39298712 | ||
| An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation | Q39394218 | ||
| Pathogen-specific risk factors and protective factors for acute diarrheal disease in urban Brazilian infants | Q39412432 | ||
| Isolation of reovirus-like agents from patients with Crohn's disease | Q39437948 | ||
| Asymptomatic endemic rotavirus infections in the newborn | Q39492190 | ||
| Diarrheal deaths in American children. Are they preventable? | Q39616251 | ||
| Human Reovirus-like Agent as the Major Pathogen Associated with “Winter” Gastroenteritis in Hospitalized Infants and Young Children | Q39981162 | ||
| Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children | Q40043630 | ||
| Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope | Q40049170 | ||
| Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children | Q40079464 | ||
| Human reovirus-like agent infection. Occurrence in adult contacts of pediatric patients with gastroenteritis | Q40079834 | ||
| Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus | Q40101068 | ||
| Central Nervous System Involvement in Patients with Rotavirus Gastroenteritis | Q40137340 | ||
| Rotaviruses: A Review | Q40137762 | ||
| The immunoprophylaxis of of rotavirus infections in lambs | Q40142913 | ||
| Studies on cross protection induced in calves by rotaviruses of calves, children and foals | Q40168374 | ||
| Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year | Q40174088 | ||
| Molecular epidemiology of rotavirus in children attending day care centers in Houston | Q68478009 | ||
| Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants | Q68484087 | ||
| Rotavirus-specific antibody response in saliva of infants with rotavirus diarrhea | Q68484109 | ||
| Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants | Q68917848 | ||
| Prolonged efficacy of rhesus rotavirus vaccine in Swedish children | Q69334937 | ||
| Studies on rotavirus homologous and heterologous active immunity in infant mice | Q69355666 | ||
| Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody | Q69807670 | ||
| Development of nasal, fecal and serum isotype-specific antibodies in calves challenged with bovine coronavirus or rotavirus | Q69817949 | ||
| Serotype-specific antibodies to rotavirus in human colostrum and breast milk and in maternal and cord blood | Q69834390 | ||
| Field trial of rhesus rotavirus vaccine in infants | Q69839488 | ||
| Murine intestinal intraepithelial lymphocytes I. Relationship of a novel Thy-1-,Lyt-1-,Lyt-2+, granulated subpopulation to natural killer cells and mast cells | Q69858855 | ||
| Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody | Q70110252 | ||
| Diverse serologic response to rotavirus infection of infants in a single epidemic | Q70120021 | ||
| The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study | Q70125528 | ||
| Immune response of infants and children to low-passage bovine rotavirus (strain WC3) | Q70131568 | ||
| Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children | Q70138090 | ||
| Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months | Q70147251 | ||
| Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children | Q70148962 | ||
| Modulation of rotavirus enteritis during breast-feeding. Implications on alterations in the intestinal bacterial flora | Q70149875 | ||
| Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge | Q70180815 | ||
| Serotype determination of human rotavirus isolates and antibody prevalence in pediatric population in Hokkaido, Japan | Q70221657 | ||
| Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants | Q70345379 | ||
| Fecal antibody responses to symptomatic and asymptomatic rotavirus infections | Q70579479 | ||
| Epidemiology of rotaviruses in a cohort of 45 Guatamalan Mayan Indian children observed from birth to the age of three years | Q71043364 | ||
| Rotavirus shedding by newborn children | Q72398186 | ||
| Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine | Q72578133 | ||
| The effect of human milk fractions on rotavirus in relation to the secretory IgA content | Q72851745 | ||
| Chronic rotavirus infection in immunodeficiency | Q72853639 | ||
| Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man | Q72920866 | ||
| Epidemiology of Human Rotavirus Types 1 and 2 as Studied by Enzyme-Linked Immunosorbent Assay | Q40180027 | ||
| Serum and intestinal immune response to rotavirus enteritis in children. | Q40184374 | ||
| Rotavirus Infections in Families: A Clinical and Virological Study | Q40192637 | ||
| Rotaviral Immunity in Gnotobiotic Calves: Heterologous Resistance to Human Virus Induced by Bovine Virus | Q40200919 | ||
| Diversity of rotavirus serotypes in Mexican infants with gastroenteritis | Q40201426 | ||
| Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11 | Q40212910 | ||
| Epidemiological survey of human rotavirus serotypes and electropherotypes in young children admitted to two children's hospitals in northeast London from 1984 to 1990 | Q40213807 | ||
| Analysis of human rotavirus strains prevailing in Bangladesh in relation to nationwide floods brought by the 1988 monsoon | Q40213872 | ||
| Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves | Q40216375 | ||
| Common Exposure Outbreak of Gastroenteritis Due to Type 2 Rotavirus with High Secondary Attack Rate within Families | Q40268332 | ||
| Reovirus-like calf enteritis | Q40570053 | ||
| Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. | Q40742565 | ||
| Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. | Q40761869 | ||
| An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group | Q40762520 | ||
| Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season | Q40783935 | ||
| Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation | Q40793640 | ||
| Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children | Q40799296 | ||
| Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. | Q40800035 | ||
| Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants | Q40812933 | ||
| Effect of breast-feeding on morbidity in rotavirus gastroenteritis. | Q40825626 | ||
| Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine | Q41241678 | ||
| Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children | Q41440921 | ||
| Sudden infant death syndrome associated with rotavirus infection | Q41465178 | ||
| Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection | Q41549991 | ||
| Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc | Q41563659 | ||
| Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins | Q41638024 | ||
| Expression of rotavirus proteins encoded by alternative open reading frames of genome segment 11. | Q41693535 | ||
| Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. | Q41902985 | ||
| Annual rotavirus epidemic patterns in North America. Results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. Rotavirus Study Group | Q42039083 | ||
| Characterization of monoclonal antibodies against human rotavirus hemagglutinin | Q43435061 | ||
| Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants | Q43482843 | ||
| Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa | Q43492399 | ||
| Human rotavirus-like particles in a hepatic abscess | Q43537356 | ||
| Aseptic meningitis in an infant with rotavirus gastroenteritis | Q43547170 | ||
| Prevention of Human Rotavirus-Induced Diarrhea in Gnotobiotic Piglets using Bovine Antibody | Q43555515 | ||
| Vaccinia—rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea | Q43601287 | ||
| Levels of colostral antibodies against neonatal calf diaahoea virus | Q43641634 | ||
| Epitope-specific immune responses to rotavirus vaccination | Q43677474 | ||
| Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural Bangladesh | Q43744091 | ||
| Failure of live, attenuated oral rotavirus vaccine | Q43753182 | ||
| Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype | Q43921519 | ||
| Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection | Q44029709 | ||
| Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus | Q44083567 | ||
| Association of Rotavirus Infection with Kawasaki Syndrome | Q44163321 | ||
| Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa | Q44336940 | ||
| Rotavirus serotype-specific neutralizing activity in human milk. | Q44360061 | ||
| Rotavirus infection in lambs: studies on passive protection | Q44551250 | ||
| Diarrhea in breast-fed and non-breast-fed infants. | Q44556515 | ||
| Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak | Q44626224 | ||
| Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody | Q44766244 | ||
| Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses | Q44775398 | ||
| Simultaneous Administration of Two Human-Rhesus Rotavirus Reassortant Strains of VP7 Serotype 1 and 2 Specificity to Infants and Young Children | Q45197533 | ||
| Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential | Q45775698 | ||
| Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes | Q45777282 | ||
| Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural Bangladesh | Q45800527 | ||
| Further observations on the virus of epizootic diarrhea of infant mice. An electron microscopic study | Q45813904 | ||
| Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands | Q45839159 | ||
| Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. | Q45996761 | ||
| Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants | Q46129217 | ||
| Animal model of rotavirus infection in rabbits--protection obtained without shedding of viral antigen | Q46147910 | ||
| VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies | Q46156185 | ||
| Natural infection of porcine ileal dome M cells with rotavirus and enteric adenovirus | Q46459314 | ||
| Serotype variation of human group A rotaviruses in two regions of the USA. | Q46701993 | ||
| A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus | Q47267339 | ||
| Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory | Q34225394 | ||
| Human rotavirus in lambs: infection and passive protection | Q34430696 | ||
| Sequential rotavirus infections: characterization of serotypes and electrophoretypes | Q34493380 | ||
| Protection from Rotavirus Reinfection: 2-Year Prospective Study | Q34497453 | ||
| Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity | Q34525698 | ||
| Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: a three-year study. | Q34556665 | ||
| IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans | Q34614781 | ||
| Electron-Microscopic Study of the Intestinal Epithelium of Mice Infected with the Agent of Epizootic Diarrhea of Infant Mice (EDIM Virus). | Q35972644 | ||
| Chronic enteric virus infection in two T-cell immunodeficient children | Q36326476 | ||
| The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions | Q36342226 | ||
| Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin | Q36344591 | ||
| Virus-Specific Immunity in Neonatal and Adult Mouse Rotavirus Infection | Q36344958 | ||
| Immunofluorescence in duodenal mucosa of children with acute enteritis due to a new virus | Q36589024 | ||
| The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data | Q36640420 | ||
| Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers | Q36656398 | ||
| Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection | Q36682098 | ||
| Serologic and mucosal immune response to rotavirus infection in the rabbit model | Q36689019 | ||
| VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection | Q36694578 | ||
| Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus | Q36694775 | ||
| Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes | Q36783022 | ||
| The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression | Q36783893 | ||
| Development of an adult mouse model for studies on protection against rotavirus | Q36784254 | ||
| Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice | Q36796390 | ||
| Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge | Q36803819 | ||
| Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. | Q36820963 | ||
| Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes | Q36825807 | ||
| Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection | Q36829980 | ||
| Identification of the two rotavirus genes determining neutralization specificities. | Q36856808 | ||
| Cultivation and characterization of three strains of murine rotavirus | Q36857827 | ||
| Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. | Q36863274 | ||
| Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus | Q36866633 | ||
| Rabbit model of rotavirus infection | Q36866742 | ||
| Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. | Q36871958 | ||
| Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen | Q36875550 | ||
| A murine model for oral infection with a primate rotavirus (simian SA11) | Q36892682 | ||
| Reassortant rotaviruses as potential live rotavirus vaccine candidates | Q36899609 | ||
| Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies | Q36900226 | ||
| Rotavirus gene structure and function | Q37055891 | ||
| Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows | Q37105594 | ||
| Distribution of serotypes of human rotavirus in different populations | Q37118338 | ||
| Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays | Q37119675 | ||
| Role of coproantibody in clinical protection of children during reinfection with rotavirus | Q37123090 | ||
| Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. | Q37141431 | ||
| Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children | Q37147641 | ||
| Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis | Q37156618 | ||
| Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates | Q37164301 | ||
| Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. | Q37169945 | ||
| Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. | Q37171840 | ||
| Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge | Q37172595 | ||
| Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. | Q37185007 | ||
| Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. | Q37212147 | ||
| Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis | Q37213643 | ||
| Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. | Q37214367 | ||
| Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants | Q37228110 | ||
| Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989. | Q37233913 | ||
| Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution | Q37239378 | ||
| Murine intestinal antibody response to heterologous rotavirus infection | Q37241347 | ||
| Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus | Q37256165 | ||
| Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses | Q37260089 | ||
| Antigenic relationships among some animal rotaviruses: virus neutralization in vitro and cross-protection in piglets | Q37297627 | ||
| Immunity to rotavirus in conventional neonatal calves | Q37300615 | ||
| Persistence of antibodies to rotavirus in human milk | Q37312403 | ||
| The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region | Q37484387 | ||
| Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity | Q37558684 | ||
| Passive immunity in rotaviral infections | Q37829300 | ||
| Molecular biology of rotaviruses | Q37895469 | ||
| Molecular determinant of rotavirus neutralization and protection | Q38203578 | ||
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 161-202 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Advances in Virus Research | Q15753074 |
| P1476 | title | Rotaviruses: immunological determinants of protection against infection and disease | |
| Rotaviruses: Immunological Determinants of Protection Against Infection and Disease | |||
| P478 | volume | 44 |
| Q40011012 | Classification of rotavirus into G and P types with specimens from children with acute diarrhea in New Delhi, India. |
| Q77379072 | Development of a rapid and sensitive quantitative assay for rotavirus based on flow cytometry |
| Q46243057 | Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors |
| Q79958029 | Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study |
| Q39879904 | Evaluation of oral Lanzhou lamb rotavirus vaccine via passive transfusion with CD4(+)/CD8(+) T lymphocytes |
| Q52648250 | Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine. |
| Q34460747 | Future vaccines: recent advances and future prospects |
| Q37473348 | Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model |
| Q52231287 | Microparasite population dynamics and continuous immunity. |
| Q40737208 | Rotavirus Vaccines: Current Controversies and Future Directions |
| Q33736259 | Rotavirus infections: guidelines for treatment and prevention |
| Q41289871 | Rotavirus vaccines: a perspective |
| Q26996393 | Rotaviruses |
| Q37058335 | Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond |
| Q39579948 | Viral determinants of rotavirus pathogenicity in pigs: evidence that the fourth gene of a porcine rotavirus confers diarrhea in the homologous host |
| Q93238844 | Viral gastroenteritis: Causes, pathophysiology, immunology, treatment, and epidemiology |
Search more.